Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ae37d2d8b123fcbcef2fbdc9a57937b |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
filingDate |
2012-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c65422d61ac1f949fe381a811eb2ae5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_328b2583d5cdf1d201eb35c425ee4699 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c35a2b08c569118e8744e3c577989294 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_739f9df93fa2edd2c414de5cda34393e |
publicationDate |
2012-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2012201450-A1 |
titleOfInvention |
Methods and compositions for deterring abuse of orally administered pharmaceutical products |
abstract |
This invention relates to an abuse deterrent formulation of an oral dosage form of a therapeutically effective amount of any active drug substance that can be subject to abuse combined with a gel forming polymer, a nasal mucosal irritating surfactant and a flushing agent. Such a dosage form is intended to deter abuse of the active drug substance via injection, nasal inhalation or consumption of quantities of the dosage unit exceeding the usual therapeutically effective dose. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11077196-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017148924-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017148919-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017148927-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3560484-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3210596-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10702607-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3210630-A1 |
priorityDate |
2004-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |